UroGen Pharma (URGN) Other Gross PP&E Adjustments: 2016-2025
Historic Other Gross PP&E Adjustments for UroGen Pharma (URGN) over the last 9 years, with Sep 2025 value amounting to -$183,000.
- UroGen Pharma's Other Gross PP&E Adjustments fell 104.86% to -$183,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.3 million, marking a year-over-year decrease of 670.60%. This contributed to the annual value of -$9.8 million for FY2024, which is 8.98% down from last year.
- Latest data reveals that UroGen Pharma reported Other Gross PP&E Adjustments of -$183,000 as of Q3 2025, which was down 123.46% from $780,000 recorded in Q2 2025.
- UroGen Pharma's 5-year Other Gross PP&E Adjustments high stood at $3.8 million for Q3 2024, and its period low was -$9.8 million during Q4 2024.
- Over the past 3 years, UroGen Pharma's median Other Gross PP&E Adjustments value was $2.1 million (recorded in 2023), while the average stood at $30,273.
- In the last 5 years, UroGen Pharma's Other Gross PP&E Adjustments skyrocketed by 606.87% in 2021 and then slumped by 104.86% in 2025.
- Over the past 5 years, UroGen Pharma's Other Gross PP&E Adjustments (Quarterly) stood at -$7.9 million in 2021, then declined by 19.45% to -$9.5 million in 2022, then rose by 5.34% to -$9.0 million in 2023, then decreased by 8.98% to -$9.8 million in 2024, then tumbled by 104.86% to -$183,000 in 2025.
- Its Other Gross PP&E Adjustments stands at -$183,000 for Q3 2025, versus $780,000 for Q2 2025 and $868,000 for Q1 2025.